Prasad Raju

Insider profile

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 44% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Prasad Raju's trades of CRISPR Therapeutics AG's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-24 2026-03-23 S Sale
53,953 -26.1%
290.24
US$3,932,237
53,953 -26.1% 290.24 US$3,932,237
2026-03-17 2026-03-16 S Sale
82,588 -40.1%
438.25
US$2,222,132
82,588 -40.1% 438.25 US$2,222,132
2026-03-17 2026-03-16 S Sale
46,477 +46.6%
231.82
US$3,247,394
46,477 +46.6% 231.82 US$3,247,394
2026-01-26 2026-01-22 PlS Planned sale
34,972 -83.8%
60.19
US$2,104,965
34,972 -83.8% 60.19 US$2,104,965
2026-01-22 2026-01-22 PrS Proposed sale
34,972
60.19
US$2,105,070
34,972 60.19 US$2,105,070
2026-01-08 2026-01-06 PlS Planned sale
5,763 -46.0%
60.21
US$347,010
5,763 -46.0% 60.21 US$347,010
2026-01-08 2026-01-06 PlS Planned sale
5,004 -28.5%
60.00
US$300,240
5,004 -28.5% 60.00 US$300,240
2026-01-08 2026-01-06 PlS Planned sale
18,933 -51.9%
60.18
US$1,139,386
18,933 -51.9% 60.18 US$1,139,386
2026-01-06 2026-01-06 PrS Proposed sale
29,700
60.16
US$1,786,636
29,700 60.16 US$1,786,636
2025-12-23 2025-12-22 PlS Planned sale
1,000 -12.9%
56.89
US$56,886
1,000 -12.9% 56.89 US$56,886
2025-12-23 2025-12-22 PlS Planned sale
5,472 -41.3%
56.33
US$308,262
5,472 -41.3% 56.33 US$308,262
2025-12-23 2025-12-22 PlS Planned sale
3,528 -21.0%
55.10
US$194,401
3,528 -21.0% 55.10 US$194,401
2025-12-22 2025-12-22 PrS Proposed sale
10,000
55.95
US$559,548
10,000 55.95 US$559,548
2025-03-24 2025-03-21 S Sale
2,197 -11.6%
41.23
US$90,582
2,197 -11.6% 41.23 US$90,582
2025-03-18 2025-03-17 S Sale
3,762 -22.8%
41.80
US$157,252
3,762 -22.8% 41.80 US$157,252
2024-03-18 2024-03-15 S Sale
3,524 -35.2%
72.69
US$256,160
3,524 -35.2% 72.69 US$256,160